Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Has Cardinal Health (CAH) Outpaced Other Medical Stocks This Year?

Published 02/10/2020, 11:30 PM
Updated 07/09/2023, 06:31 AM

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Cardinal Health (NYSE:CAH) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.

Cardinal Health is a member of our Medical group, which includes 901 different companies and currently sits at #2 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.

The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. CAH is currently sporting a Zacks Rank of #2 (Buy).

The Zacks Consensus Estimate for CAH's full-year earnings has moved 6.41% higher within the past quarter. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.

Our latest available data shows that CAH has returned about 17.02% since the start of the calendar year. At the same time, Medical stocks have gained an average of 1.95%. This means that Cardinal Health is outperforming the sector as a whole this year.

To break things down more, CAH belongs to the Medical - Dental Supplies industry, a group that includes 22 individual companies and currently sits at #103 in the Zacks Industry Rank. On average, this group has gained an average of 3.42% so far this year, meaning that CAH is performing better in terms of year-to-date returns.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Investors with an interest in Medical stocks should continue to track CAH. The stock will be looking to continue its solid performance.



Original post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.